Ekfors T O, Lipasti J, Nurmi M J, Eerola E
Pathol Res Pract. 1987 Feb;182(1):58-62. doi: 10.1016/s0344-0338(87)80142-5.
DNA flow cytometry was applied to one hundred consecutive renal cell carcinomas from years 1974-1979. Single cell suspensions were prepared from paraffin-embedded tissue. From 96 evaluable tumours 34 were considered diploid and 62 aneuploid. Ploidy did not correlate statistically significantly with local growth, venous invasion, nodal or distant metastatic spread, or nuclear grade of renal cell carcinomas. Also the survival of the patients with diploid and aneuploid tumours was not significantly different, but, excluding patients with distant metastases at the time of extrafascial nephrectomy, 83% of the patients with diploid tumour survived for five years, while only 57% of the patients with aneuploid tumour were alive after the same time interval. The difference between survival curves is statistically almost significant (p less than 0.05). The cytologic nuclear grade predicted the prognosis more significantly (p less than 0.01), and the combination of these methods is recommended for the prognostication of renal cell carcinoma.
1974年至1979年间,对100例连续性肾细胞癌应用了DNA流式细胞术。从石蜡包埋组织制备单细胞悬液。在96例可评估肿瘤中,34例为二倍体,62例为非整倍体。倍性与肾细胞癌的局部生长、静脉侵犯、淋巴结或远处转移扩散或核分级无统计学显著相关性。二倍体和非整倍体肿瘤患者的生存率也无显著差异,但是,排除筋膜外肾切除时已有远处转移的患者,二倍体肿瘤患者83%存活5年,而非整倍体肿瘤患者在相同时间间隔后只有57%存活。生存曲线之间的差异在统计学上几乎具有显著性(p小于0.05)。细胞学核分级对预后的预测更具显著性(p小于0.01),建议将这些方法联合用于肾细胞癌的预后评估。